Literature DB >> 12629128

Identification of a novel missense mutation that is as damaging to DAX-1 repressor function as a nonsense mutation.

Pamela Brown1, Graeme A Scobie, Julie Townsend, Rosemary A L Bayne, Jonathan R Seckl, Philippa T K Saunders, Richard A Anderson.   

Abstract

Mutations in the DAX-1 (NROB1) gene result in X-linked congenital adrenal hypoplasia (AHC) and hypogonadotropic hypogonadism. The clinical presentation is usually as adrenal insufficiency in early life, with hypogonadotropic hypogonadism detected at the time of expected puberty. In this study we identified mutations in the DAX-1 gene of two patients with AHC. One mutation, Y399X, resulted in a premature stop codon and was associated with loss of Leydig cell responsiveness to human chorionic gonadotropin. The second, L297P, was a missense mutation, and human chorionic gonadotropin responsiveness was maintained. Kindred analysis established that the mutations had been inherited from the proband's mothers. The L297P has not been described previously and occurs within a highly conserved binding motif (LLXLXL). Transient transfection assays demonstrated that both mutations resulted in a severe loss of DAX-1 repressor activity. Immunohistochemical analysis of testicular tissue obtained from an affected sibling of the subject with the Y399X mutation, who had died with adrenal failure as a neonate, showed normal testicular morphology and expression of DAX-1, steroidogenic factor-1, and anti-Mullerian hormone protein. These data extend the clinical and molecular information on DAX-1 mutations, confirm normal testicular development at the neonatal stage, and illustrate variability in Leydig cell function.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12629128     DOI: 10.1210/jc.2002-021560

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  11 in total

1.  Two novel DAX1 gene mutations in Chinese patients with X-linked adrenal hypoplasia congenita: clinical, hormonal and genetic analysis.

Authors:  C M Wu; H B Zhang; Q Zhou; L Wan; J Jin; L Ni; Y J Pan; X Y Wu; L Y Ruan
Journal:  J Endocrinol Invest       Date:  2011-01-26       Impact factor: 4.256

Review 2.  Viral infection and human disease--insights from minimotifs.

Authors:  Krishna Kadaveru; Jay Vyas; Martin R Schiller
Journal:  Front Biosci       Date:  2008-05-01

Review 3.  Hypogonadotropic hypogonadism in subjects with DAX1 mutations.

Authors:  Unmesh Jadhav; Rebecca M Harris; J Larry Jameson
Journal:  Mol Cell Endocrinol       Date:  2011-06-13       Impact factor: 4.102

4.  A novel missense mutation in DAX-1 with an unusual presentation of X-linked adrenal hypoplasia congenita.

Authors:  Imran Ahmad; Wendy F Paterson; Lin Lin; Peter Adlard; Philippa Duncan; John Tolmie; John C Achermann; Malcolm D C Donaldson
Journal:  Horm Res       Date:  2007-02-16

5.  Birth after TESE-ICSI in a man with hypogonadotropic hypogonadism and congenital adrenal hypoplasia linked to a DAX-1 (NR0B1) mutation.

Authors:  C Frapsauce; C Ravel; M Legendre; M Sibony; J Mandelbaum; B Donadille; J C Achermann; J-P Siffroi; S Christin-Maitre
Journal:  Hum Reprod       Date:  2011-01-11       Impact factor: 6.918

6.  Proline-rich tyrosine kinase 2 mediates gonadotropin-releasing hormone signaling to a specific extracellularly regulated kinase-sensitive transcriptional locus in the luteinizing hormone beta-subunit gene.

Authors:  Stuart Maudsley; Zvi Naor; David Bonfil; Lindsay Davidson; Dimitra Karali; Adam J Pawson; Rachel Larder; Caroline Pope; Nancy Nelson; Robert P Millar; Pamela Brown
Journal:  Mol Endocrinol       Date:  2007-02-27

7.  Analysis of DAX1 (NR0B1) and steroidogenic factor-1 (NR5A1) in children and adults with primary adrenal failure: ten years' experience.

Authors:  Lin Lin; Wen-Xia Gu; Gokhan Ozisik; Wing S To; Catherine J Owen; J Larry Jameson; John C Achermann
Journal:  J Clin Endocrinol Metab       Date:  2006-05-09       Impact factor: 5.958

8.  Longitudinal evaluation of the hypothalamic-pituitary-testicular function in 8 boys with adrenal hypoplasia congenita (AHC) due to NR0B1 mutations.

Authors:  Caroline Galeotti; Zineb Lahlou; Domitille Goullon; Hélène Sarda-Thibault; Juliette Cahen-Varsaux; Joëlle Bignon-Topalovic; Anu Bashamboo; Ken McElreavey; Raja Brauner
Journal:  PLoS One       Date:  2012-06-27       Impact factor: 3.240

9.  Effect of Recombinant Gonadotropin on Testicular Function and Testicular Sperm Extraction in Five Cases of NR0B1 (DAX1) Pathogenic Variants.

Authors:  Jordan Teoli; Vincent Mezzarobba; Lucie Renault; Delphine Mallet; Hervé Lejeune; Pierre Chatelain; Frédérique Tixier; Marc Nicolino; Noël Peretti; Sandrine Giscard D'estaing; Béatrice Cuzin; Frédérique Dijoud; Florence Roucher-Boulez; Ingrid Plotton
Journal:  Front Endocrinol (Lausanne)       Date:  2022-03-30       Impact factor: 5.555

10.  The DAX1 mutation in a patient with hypogonadotropic hypogonadism and adrenal hypoplasia congenita causes functional disruption of induction of spermatogenesis.

Authors:  Donata Ponikwicka-Tyszko; Malgorzata Kotula-Balak; Katarzyna Jarzabek; Barbara Bilinska; Slawomir Wolczynski
Journal:  J Assist Reprod Genet       Date:  2012-05-05       Impact factor: 3.412

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.